• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基底神经节中的钾通道:治疗帕金森病的有前景的新靶点。

Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.

作者信息

Wang Gang, Zeng Jie, Ren Rujing, Chen Shengdi

机构信息

Department of Neurology and Institute of Neuroscience, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

出版信息

Front Biosci. 2008 May 1;13:3685-98. doi: 10.2741/2959.

DOI:10.2741/2959
PMID:18508465
Abstract

A large number studies indicate that potassium (K+) channels play important roles in cellular signaling in both excitable and nonexcitable cells. Moreover, a considerable number of K+ channels within the nervous system appear to mediate diverse cellular signaling, including regulation of neurotransmitter release, neuronal excitability, and cell volume. Recent studies on the K+ channel gene expression in the basal ganglia reveal dysfunctions of various K+ channels (e.g., Kv, K(ATP), Kir2 and SKCa), which may be involved in the pathogenesis of Parkinson's disease (PD). This review aims to provide an overview of our current understanding of the molecular mechanisms involved in K+ channel functions in the basal ganglia, and an insight on how to exploit K+ channels as therapeutic targets in the treatment of PD.

摘要

大量研究表明,钾离子(K+)通道在可兴奋细胞和非可兴奋细胞的细胞信号传导中均发挥着重要作用。此外,神经系统内相当数量的K+通道似乎介导多种细胞信号传导,包括神经递质释放的调节、神经元兴奋性和细胞体积。最近关于基底神经节中K+通道基因表达的研究揭示了各种K+通道(如Kv、K(ATP)、Kir2和SKCa)的功能障碍,这可能与帕金森病(PD)的发病机制有关。本综述旨在概述我们目前对基底神经节中K+通道功能所涉及分子机制的理解,并深入探讨如何将K+通道作为治疗靶点用于PD的治疗。

相似文献

1
Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.基底神经节中的钾通道:治疗帕金森病的有前景的新靶点。
Front Biosci. 2008 May 1;13:3685-98. doi: 10.2741/2959.
2
Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.基底神经节中的钾通道:治疗帕金森病的新的有前景的靶点。
Front Biosci. 2008 May 1;13:3825-38. doi: 10.2741/2971.
3
Potassium channels: possible new therapeutic targets in Parkinson's disease.钾通道:帕金森病潜在的新治疗靶点
Med Hypotheses. 2008 Oct;71(4):546-50. doi: 10.1016/j.mehy.2008.05.021. Epub 2008 Jul 22.
4
Parkinson's disease: a major hypokinetic basal ganglia disorder.帕金森病:一种主要的运动减少型基底神经节疾病。
J Neural Transm (Vienna). 1999;106(5-6):443-76. doi: 10.1007/s007020050171.
5
Basal ganglia, Parkinson's disease and levodopa therapy. Proceedings of a meeting. St Thomas, Virgin Islands, January 2000.基底神经节、帕金森病与左旋多巴治疗。一次会议的会议记录。美属维尔京群岛圣托马斯,2000年1月
Trends Neurosci. 2000 Oct;23(10 Suppl):S1-126.
6
Parkinson's disease and its chemotherapy.帕金森病及其化学疗法。
Biochem Pharmacol. 1975 May 15;24(10):1061-5. doi: 10.1016/0006-2952(75)90190-2.
7
Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease.钾通道:帕金森病的潜在治疗靶点。
Neurosci Bull. 2018 Apr;34(2):341-348. doi: 10.1007/s12264-017-0177-3. Epub 2017 Sep 7.
8
The role of glutamate in the pathophysiology of Parkinson's disease.谷氨酸在帕金森病病理生理学中的作用。
Funct Neurol. 1996 Jan-Feb;11(1):3-15.
9
Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.基底神经节的功能组织:对帕金森病的治疗意义
Mov Disord. 2008;23 Suppl 3:S548-59. doi: 10.1002/mds.22062.
10
Chemical signalling in the globus pallidus in parkinsonism.
Prog Brain Res. 1993;99:125-39. doi: 10.1016/s0079-6123(08)61342-4.

引用本文的文献

1
Blockade of fast A-type and TEA-sensitive potassium channels provide an antiparkinsonian effect in a 6-OHDA animal model.在6-羟基多巴胺动物模型中,阻断快速A型和四乙铵敏感钾通道可产生抗帕金森病效应。
Neurosciences (Riyadh). 2017 Jan;22(1):44-50. doi: 10.17712/nsj.2017.1.20160266.